NCT00882375

Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy

Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy. A Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel Group, 52 Week Study in Smokers Motivated to Quit.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 479 (actual)
• Sponsor: McNeil AB · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A comparison of a novel nicotine replacement therapy and placebo treatment in smokers motivated to quit smoking.

Detailed description

Efficacy and safety study following use of a novel nicotine replacement therapy.

Conditions

• Smoking Cessation

Interventions

Type	Name	Description
DRUG	Nicotine	Nicotine administered using novel NRT user instructions
DRUG	Placebo	Placebo administered using novel NRT user instructions

Timeline

• Start date: 2009-03-01
• Primary completion: 2010-06-01
• Completion: 2010-06-01
• First posted: 2009-04-16
• Last updated: 2012-07-02

Locations

3 sites across 2 countries: Denmark, Germany